Resource Hub

Einstein Antibody Test Ready for Widespread Use

Amidst a nationwide shortage of antibody tests for the novel coronavirus, a test developed and validated by Einstein scientists and Montefiore clinical pathologists was submitted on May 4 to the New York State Department of Health (NYSDOH) for approval as a laboratory developed test (LDT).

Einstein-Invented Compound Now Being Tested in COVID-19 Clinical Trial

A compound originally discovered by Albert Einstein College of Medicine’s Vern Schramm, Ph.D., is being evaluated by BioCryst Pharmaceuticals, Inc., in Brazil as a treatment for COVID-19 patients. The randomized, double-blind, placebo-controlled trial is funded by the National Institute of Allergy and Infectious Diseases.

COVID-19

This site offers information to help you take action and stay up to date on COVID-19 news and recommendations. Below, please find links to recent communications, important updates, and useful resources about COVID-19.Updates for Community

Combating the COVID-19 Pandemic with Antibodies and a Patient Database

Along with many other Einstein and Montefiore scientists and physicians, infectious disease expert Liise-anne Pirofski, M.D., is working overtime to confront COVID-19. She is spearheading two important projects.